company background image
A298380 logo

ABL Bio KOSDAQ:A298380 Stock Report

Last Price

₩27.65k

Market Cap

₩1.4t

7D

-16.2%

1Y

38.4%

Updated

21 Nov, 2024

Data

Company Financials +

A298380 Stock Overview

A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. More details

A298380 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ABL Bio Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ABL Bio
Historical stock prices
Current Share Price₩27,650.00
52 Week High₩43,300.00
52 Week Low₩18,960.00
Beta1.01
11 Month Change-31.39%
3 Month Change-12.22%
1 Year Change38.39%
33 Year Change35.54%
5 Year Change47.86%
Change since IPO102.56%

Recent News & Updates

Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30%

Nov 20
Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30%

Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

May 29
Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

Recent updates

Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30%

Nov 20
Some Confidence Is Lacking In ABL Bio Inc. (KOSDAQ:298380) As Shares Slide 30%

Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

May 29
Is ABL Bio (KOSDAQ:298380) Using Too Much Debt?

Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?

Feb 26
Is ABL Bio (KOSDAQ:298380) Weighed On By Its Debt Load?

We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth

Mar 31
We Think ABL Bio (KOSDAQ:298380) Can Afford To Drive Business Growth

Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?

Jan 20
Should ABL Bio (KOSDAQ:298380) Be Disappointed With Their 33% Profit?

Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth

Dec 16
Companies Like ABL Bio (KOSDAQ:298380) Are In A Position To Invest In Growth

Shareholder Returns

A298380KR BiotechsKR Market
7D-16.2%-3.0%2.3%
1Y38.4%22.4%-3.8%

Return vs Industry: A298380 exceeded the KR Biotechs industry which returned 22.4% over the past year.

Return vs Market: A298380 exceeded the KR Market which returned -3.8% over the past year.

Price Volatility

Is A298380's price volatile compared to industry and market?
A298380 volatility
A298380 Average Weekly Movement10.4%
Biotechs Industry Average Movement8.1%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.4%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A298380's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A298380's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aSang Hoon Leewww.ablbio.com

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.

ABL Bio Inc. Fundamentals Summary

How do ABL Bio's earnings and revenue compare to its market cap?
A298380 fundamental statistics
Market cap₩1.39t
Earnings (TTM)-₩88.43b
Revenue (TTM)₩32.32b

41.1x

P/S Ratio

-15.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A298380 income statement (TTM)
Revenue₩32.32b
Cost of Revenue₩61.87m
Gross Profit₩32.26b
Other Expenses₩120.69b
Earnings-₩88.43b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.84k
Gross Margin99.81%
Net Profit Margin-273.60%
Debt/Equity Ratio23.8%

How did A298380 perform over the long term?

See historical performance and comparison